New diagnostic tests: More harm than good

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Hofmann, Bjørn ^a   Welch, H Gilbert ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADMINISTRATIVE CLAIMS (HEALTH CARE); ALZHEIMER DISEASE; BREATH ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; EVIDENCE BASED PRACTICE; FINANCIAL MANAGEMENT; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; IMMUNOSIGNATURE; MEDICAL DECISION MAKING; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; AMBULATORY MONITORING; DECISION MAKING; GENETIC PROCEDURES; MEDICAL INFORMATICS; MOBILE APPLICATION; PREVENTION AND CONTROL; REPRODUCIBILITY; TRENDS;

BIOMARKERS; BIOSENSING TECHNIQUES; DECISION MAKING; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; MEDICAL INFORMATICS APPLICATIONS; MOBILE APPLICATIONS; MONITORING, AMBULATORY; REPRODUCIBILITY OF RESULTS;

EID: 85024857776     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j3314     Document Type: Review

References (32)

1. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine
2. Nat Rev Clin Oncol, 2011, 8, 184-7, 10.1038/nrclinonc.2010.227
3. Legutki JB, Zhao ZG, Greving M, Woodbury N, Johnston SA, Stafford P. Scalable high-density peptide arrays for comprehensive health monitoring. Nat Commun 2014;5:4785. doi:10.1038/ncomms5785
4. Sykes KF, Legutki JB, Stafford P. Immunosignaturing: A critical review. Trends Biotechnol 2013;31:45-51. doi:10.1016/j.tibtech.2012.10.012
5. Stafford P, Cichacz Z, Woodbury NW, Johnston SA. Immunosignature system for diagnosis of cancer. Proc Natl Acad Sci U S A 2014;111:E3072-80. doi:10.1073/pnas 1409432111
6. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-30. doi:10.1056/NEJM197810262991705 pmid:692598
7. Dent AG, Sutedja TG, Zimmerman PV. Exhaled breath analysis for lung cancer. J Thorac Dis 2013;5(Suppl 5):S540-50. doi:10.3978/j.issn.2072-1439.2013.08.44.
8. Gregory A. Cancer breath test could save 10 000 lives a year before other symptoms develop. Mirror 2015 Feb 10. http://www.mirror.co.uk/lifestyle/health/cancer-breath-Testcould-save-5135643
9. Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: The role of novel biomarkers. Lung 2014;192:639-48. doi:10.1007/s00408-014-9636-z
10. Gadsden G. Medical breakthrough: Diagnosing disease could be a breath away. Click Orlando 2014 September 10. http://www.clickorlando.com/news/medical-breakthroughdiagnosing-disease-could-be-A-breath-Away
11. Krilaviciute A, Heiss JA, Leja M, Kupcinskas J, Haick H, Brenner H. Detection of cancer through exhaled breath: A systematic review. Oncotarget 2015;6:38643-57. doi:10.18632/oncotarget.5938.
12. Fung E, Järvelin MR, Doshi RN, et al. Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol 2015;6:149. doi:10.3389/fphys 2015.00149
13. Zephyr Technology. BioPatch wireless device. 2014 http://zephyranywhere.com
14. van Veldhuisen DJ, Braunschweig F, Conraads V, et al. DOT-HF Investigators Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011;124:1719-26. doi:10.1161/CIRCULATIONAHA.111 043042
15. Kiddle SJ, Sattlecker M, Proitsi P, et al. Candidate blood proteome markers of Alzheimers disease onset and progression: A systematic review and replication study. J Alzheimers Dis 2014;38:515-31. doi:10.3233/jad-130380.
16. Weinstein G, Seshadri S. Circulating biomarkers that predict incident dementia. Alzheimers Res Ther 2014;6:6. doi:10.1186/alzrt235
17. Dowling L. Study says blood test for brain insulin resistance accurately predicts Alzheimers disease risk. Nanosomix. 2014 http://www.nanosomix.com/p2
18. OBryant SE, Mielke MM, Rissman RA, et al. Biofluid Based Biomarker Professional Interest Area. Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2017;13:45-58. doi:10.1016/j.jalz.2016.09.014
19. Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 2014;20:415-8. doi:10.1038/nm.3466 pmid: 24608097
20. Coart E, Barrado LG, Duits FH, et al. Alzheimers Disease Neuroimaging Initiative Correcting for the absence of a gold standard improves diagnostic accuracy of biomarkers in Alzheimers disease. J Alzheimers Dis 2015;46:889-99. doi:10.3233/JAD-142886
21. TellHealth. HealthTell reaches 13.5 million for launch of disruptive diagnostic platform 2014 http://www.healthtell.com/news/healthtell-reaches-13-5-million-launch-disruptivediagnostic-platform/
22. Hibbard C. HealthTell Inc completes a 26 million series B financing. 2016. http://www prnewswire.com/news-releases/healthtell-inc-completes-A-26-million-series-b-financing-300235271.html
23. Grand View Research. Breath analyzer market size to reach 11.3 billion by 2024. 2016 http://www.grandviewresearch.com/press-release/global-breath-Analyzer-market
24. Qualcomm. Introducing Qualcomm life. Mobilizing health care. 2014 http://www qualcommlife.com/company-overview
25. Kronemeyer B. Blood test for early detection of Alzheimers disease. Start-Up, 2014
26. Highsmith J. Biomarkers: Technologies and global markets. BCC Research, 2014
27. Mobile health (mHealth) technology and global markets. [program] BCC Research, 2014
28. Highsmith J. Biomarkers: Technologies and global markets. BCC Research, 2016
29. Welch G, Schwartz L, Woloshin S. Overdiagnosed: making people sick in pursuit of health Beacon Press, 2011
30. Hardesty LA, Lind KE, Gutierrez EJ. Compliance with screening mammography guidelines after a false-positive mammogram. J Am Coll Radiol 2016;13:1032-8. doi:10.1016/j.jacr 2016.03.016
31. Siontis KC, Siontis GC, Contopoulos-Ioannidis DG, Ioannidis JP. Diagnostic tests often fail to lead to changes in patient outcomes. J Clin Epidemiol 2014;67:612-21. doi:10.1016/j.jclinepi.2013.12.008
32. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med 1986;314:512-4. doi:10.1056/NEJM198602203140809